BioSpace News Archive

Microbot Medical Inc. announces that an additional milestone was achieved when medical professionals experienced the Company’s LIBERTY Robotic Surgical System as part of a formative study.

Indaptus Therapeutics, Inc. announced today that CEO Jeffrey A. Meckler will present a corporate overview at the Jefferies Healthcare Conference 2023.

Prelude Therapeutics Incorporated announced today that the company will participate in the Jefferies Healthcare Conference, taking place in New York City, June 7 to 9, 2023.

Argon Medical Devices announced the launch of the SuperCore Advantage™ Semi-Automatic Biopsy Instrument as the newest addition to its soft tissue biopsy product portfolio in the United States.

Tissue Dynamics, a disruptive AI/ML biopharma company, announced that Prof. Roger D. Kornberg, renowned biochemist and professor of structural biology at Stanford University, will be joining its advisory board.

biote Corp. today announced its participation at the following investor conferences.

Neogen® Corporation (NASDAQ: NEOG) announced today that it has launched two new assays for the detection of histamine, Reveal® for Histamine and Reveal Q+ for Histamine.

Tenax Therapeutics, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application with claims covering the use of TNX-103.

Nanalysis Scientific Corp. announces that Chief Executive Officer, Sean Krakiwsky will be presenting at the 13th nnual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023.

NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of an abstract describing partial results from a NIH-funded, multi-site randomized controlled trial of Quell titled “Wireless transcutaneous electric nerve stimulation (TENS) for chemotherapy-induced peripheral neuropathy (CIPN): A proof-of-concept, placebo-controlled, randomized clinical trial (RCT).”